| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417234 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417215 Calcilytic compounds |
| 07/09/2002 | US6417214 Compounds as contraceptives |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417199 3-benzyl-benzothiophenes |
| 07/09/2002 | US6417193 Methods for inhibiting MRP1 |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416780 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2191993C Novel synthesis of 19-nor-vitamin d compounds |
| 07/09/2002 | CA2061566C Treatment of disease employing hyaluronic acid and nsaids |
| 07/09/2002 | CA1341374C Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2 |
| 07/04/2002 | WO2002052273A1 Screening method based on siah-numb interaction |
| 07/04/2002 | WO2002052020A2 Regulation of human carboxypeptidase a |
| 07/04/2002 | WO2002052019A2 22437, a human sulfatase and uses therefor |
| 07/04/2002 | WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2002052008A1 Novel cancer-associated genes |
| 07/04/2002 | WO2002052005A1 Novel genes and proteins encoded thereby |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051867A1 A novel polypeptide-corticotropin releasing factor 8.8 and the polynucleotide encoding said polypeptide |
| 07/04/2002 | WO2002051849A1 Cdk4 inhibitors |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051846A1 Apicidin-derivatives, their synthetic methods, and antitumor compositions containing the same |
| 07/04/2002 | WO2002051842A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051834A1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051830A1 Carboxamides for use as telomerase inhibitors |
| 07/04/2002 | WO2002051821A1 Therapeutic compounds |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051805A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | WO2002051444A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051423A1 Angiogenesis inhibitors |
| 07/04/2002 | WO2002051406A1 Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051390A2 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
| 07/04/2002 | WO2002051388A2 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 07/04/2002 | WO2002051386A2 Lipid microparticles by cryogenic micronization |
| 07/04/2002 | WO2002033116A3 Nucleic acid ligands to the prostate specific membrane antigen |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002032373A3 Estrogen receptor modulators |
| 07/04/2002 | WO2002028347A3 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/04/2002 | WO2002022576A3 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors |
| 07/04/2002 | WO2002020486A3 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 07/04/2002 | WO2002017968A9 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain-2 |
| 07/04/2002 | WO2002015904B1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001078783A3 Compositions comprising natural agents for treatment of cancer |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 07/04/2002 | WO2001046176A3 Non peptide tachykinin receptor antagonists |
| 07/04/2002 | WO2001044260A9 Novel purines |
| 07/04/2002 | WO2001042470A9 Nucleic acid and protein expressed thereby and their involvement in stress |
| 07/04/2002 | WO2001041791A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/04/2002 | WO2001036007A3 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | US20020087205 Transcutaneous photodynamic treatment of targeted cells |
| 07/04/2002 | US20020087015 High intestinal calcium transport activity and relatively high bone calcium mobilization activity; treating osteoporosis, cancer, psoriasis |
| 07/04/2002 | US20020087013 Methods for preparing new taxoids and pharmaceutical compositions containing them |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086900 Methods of producing oxazolidinone compounds |
| 07/04/2002 | US20020086897 Cytotoxic agents comprising taxanes and their therapeutic use |
| 07/04/2002 | US20020086891 Substituted benzo(b)thiophenes or benzoisothiazoles which inhibit 2,3-oxidosqualene-lanosterol cyclase which is required for the biosynthesis of cholesterol, ergosterol and other sterols |
| 07/04/2002 | US20020086884 Anticancer agents based on regulation of protein prenylation |
| 07/04/2002 | US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents |
| 07/04/2002 | US20020086852 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 07/04/2002 | US20020086849 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
| 07/04/2002 | US20020086840 Use of Rad51 inhibitors for p53 gene therapy |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |